Close

GMP Cancer Vaccine Analysis and Qualification

GMP-Cancer-Vaccine-Analysis-and-Qualification Cancer vaccines consist of one or more antigenic components, including live-attenuated or killed viral or bacterial particles, proteins, polysaccharides, polynucleotides, and particle conjugates. Additionally, other excipients like adjuvants may be present. Not only the chemical and structural integrity of various components must be maintained, but the immunogenicity must be ensured. Thus, the complexity of vaccines creates a unique challenge for characterization.

As a first-class service producer, Creative Biolabs describes a wide range of analytical technologies for diverse vaccine modalities. These include cancer vaccine identification of physicochemical properties, the purification, and potency testing, and the application of both classical and modern bio-analytical tools. With the help of us, the candidate of cancer vaccines can meet and exceed the GMP requirement quickly and smoothly.

Cancer Vaccine Analysis Services at Creative Biolabs

Today, cancer vaccine is developed either as a prophylactic agent to prevent future infection or as a therapeutic treatment. Here, our vaccine development teams perform a comprehensive suite of methods to evaluate the components of cancer vaccines, including protein (glycoprotein, lipoprotein, etc.), lipid, carbohydrate, and lipopolysaccharide. Specifically, we offer total quality assurance expertise to assist clients’ products up to quality with safety and regulatory standards.

Biological Analytical Assays

  • Biopotency assessment
  • Biosafety testing
  • Stability studies
  • Bulk harvest testing
  • Cell line safety assessment
  • cGMP batch release
  • Clinical trial support
  • Neutralizing assessment
  • Protein analysis
  • Virus validation services
  • Vector safety assessment
  • Microbial testing

Physicochemical Analytical Technologies

GMP-Cancer-Vaccine-Analysis-and-Qualification
  1. Chromatography
  2. Electrophoresis
  3. Immunological assays (ELISA, WB, etc.)
  4. Mass spectrometry (MS)
  5. Nuclear magnetic resonance (NMR)
  6. High-performance liquid chromatography (HPLC)
  7. Liquid chromatography-mass spectrometry (LC-MS)
  8. Qualitative PCR (q-PCR)

Highlights from Creative Biolabs

  1. Flexible, versatile analytical techniques for the identification and characterization of cancer vaccines
  2. The deliverable results including detailed design, protocols, report, and interpretation
  3. Seasoned experts and technicians with abundant project experience
  4. Better customized services on pre- and after-sales

Creative Biolabs’ teams possess technical expertise in GMP vaccine analytical development and have gained a great reputation in the vaccine industry. We can offer specialized contract services for almost any cancer vaccines to obtain their identity, purity, efficacy, and quantity and provide GMP-compliant process development services.

Furthermore, there is another support for cancer vaccine developments and manufacture studies for stable, efficient, and potent products. If you’re interested in related services, please don’t hesitate to contact us.

Online Inquiry

For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.

  • Verification code
    Click image to refresh the verification code.

Key Updates

Receive the latest news and insights to your inbox.